Advisor Pro Platform— 510(k) K210561

Substantially Equivalent

DreaMed Diabetes, Ltd.

FDA 510(k) clearance K210561 for Advisor Pro Platform, Substantially Equivalent on 2021-09-28. Applicant: DreaMed Diabetes, Ltd.. Device class: 2.

Clearance details

Applicant: DreaMed Diabetes, Ltd.
Product code: Code QCC
Device class: Class 2
Regulation: 21 CFR 862.1358
Advisory panel: Clinical Chemistry
Date received: 2021-02-25
Decision date: 2021-09-28
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Petah Tikva, IL

Download summary PDF View on FDA.gov ↗

Recent devices under product code QCC

K232722 — endo.digital Platform2023-10-03
K201476 — DreaMed Advisor Pro2020-08-28
K191370 — DreaMed Advisor Pro2019-07-18
DEN170043 — DreaMed Advisor Pro2018-06-12

More clearances from DreaMed Diabetes, Ltd.

K260062 — MODI System2026-09-08

Data sourced from openFDA. This site is unofficial and independent of the FDA.